De La Torre Leticia Albert, Vázquez Belen Toral, Linde Dolores Herrera, Soto Alberto Mendoza, Torres Enrique García
Pediatrics Department, Pediatric Heart Institute, Research Institute Hospital 12 de Octubre (i+12), University Hospital 12 de Octubre, Madrid, Spain.
Ann Pediatr Cardiol. 2022 Mar-Apr;15(2):183-186. doi: 10.4103/apc.apc_200_21. Epub 2022 Aug 19.
The use of the Melody (Medtronic, Minneapolis, MN, USA) biological prosthesis in mitral position has shown acceptable short-term results. Furthermore, it allows its expansion with a balloon when the patient grows up, and this procedure can be performed by a venous catheterization through transseptal approach through an interatrial communication or puncturing the septum. Patients with complex congenital heart disease undergoing multiple surgical and percutaneous interventions may present with vascular complications such as thrombosis of the femoral venous system that make percutaneous access impossible. In this situation, the transhepatic approach is a very useful alternative to access the heart.
在美国明尼阿波利斯市美敦力公司生产的Melody生物假体用于二尖瓣位置时已显示出可接受的短期效果。此外,当患者长大后,可通过球囊对其进行扩张,该操作可通过经房间隔交通或穿刺隔膜的经静脉导管介入经房间隔途径来完成。患有复杂先天性心脏病且接受多次外科手术和经皮介入治疗的患者可能会出现血管并发症,如股静脉系统血栓形成,这使得经皮穿刺无法进行。在这种情况下,经肝途径是进入心脏的一种非常有用的替代方法。